Targets of protective immunity and opportunities in hepatitis C virus vaccine development
- 12 September 2025
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 26 (2) , 112-128
Abstract
Hepatitis C virus (HCV) remains a serious global health burden that affects nearly 50 million people worldwide. Despite the availability of highly effective direct-acting antiviral drugs, the lack of an effective HCV vaccine hinders control and elimination worldwide, wherein new infections and overall prevalence remain high. HCV vaccine development faces challenges including high genetic diversity of the virus, unclear correlates of protective immunity, and lack of robust in vivo models for vaccine testing. Despite these obstacles, the landscape of HCV vaccine development is rapidly evolving. Innovative strategies, including subunit, virus-like particle, viral vector, DNA and RNA vaccines, show promising results, and controlled human infection models offer a unique, albeit ethically complex, opportunity to accelerate vaccine development. Collaborative efforts among academia, industry, governmental agencies and regulatory bodies are crucial for optimizing vaccine strategies, overcoming current challenges and effecting advances towards global HCV elimination through vaccination.Keywords
This publication has 204 references indexed in Scilit:
- Novel Cd4+ and Cd8+ T–Cell Determinants Within the Ns3 Protein in Subjects With Spontaneously Resolved Hcv InfectionHepatology, 2003
- Hepatitis C virus replication in mice with chimeric human liversNature Medicine, 2001
- Hepatitis C Virus-Like Particles Induce Virus–Specific Humoral and Cellular Immune Responses in MiceHepatology, 2001
- Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCVHepatology, 2000
- Analysis of Successful Immune Responses in Persons Infected with Hepatitis C VirusJournal of Experimental Medicine, 2000
- Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virusHepatology, 1999
- Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine developmentHepatology, 1999
- Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81Journal of Virology, 1999
- Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect CellsJournal of Virology, 1998
- Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 proteinProceedings of the National Academy of Sciences, 1996